Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Sell
50,548
-472
-0.9% -$168K 0.21% 75
2025
Q4
$16.7M Sell
51,020
-843
-2% -$267K 0.19% 80
2025
Q3
$14.6M Sell
51,863
-623
-1% -$181K 0.17% 91
2025
Q2
$14.7M Sell
52,486
-1,761
-3% -$499K 0.18% 83
2025
Q1
$16.9M Buy
54,247
+2,357
+5% +$696K 0.22% 67
2024
Q4
$13.5M Sell
51,890
-1,405
-3% -$417K 0.18% 83
2024
Q3
$17.2M Buy
53,295
+1,323
+3% +$433K 0.24% 65
2024
Q2
$16.2M Sell
51,972
-1,048
-2% -$308K 0.24% 65
2024
Q1
$15.1M Buy
53,020
+951
+2% +$278K 0.23% 68
2023
Q4
$15M Sell
52,069
-7,162
-12% -$1.95M 0.25% 68
2023
Q3
$15.9M Sell
59,231
-808
-1% -$202K 0.29% 60
2023
Q2
$13.3M Sell
60,039
-3,120
-5% -$724K 0.23% 75
2023
Q1
$15.3M Sell
63,159
-695
-1% -$171K 0.28% 65
2022
Q4
$16.8M Sell
63,854
-816
-1% -$219K 0.33% 61
2022
Q3
$14.6M Sell
64,670
-1,032
-2% -$250K 0.32% 60
2022
Q2
$16M Sell
65,702
-2,739
-4% -$671K 0.34% 60
2022
Q1
$16.6M Sell
68,441
-916
-1% -$210K 0.3% 66
2021
Q4
$15.6M Sell
69,357
-7,434
-10% -$1.57M 0.26% 75
2021
Q3
$16.3M Sell
76,791
-2,688
-3% -$619K 0.29% 64
2021
Q2
$19.4M Sell
79,479
-11,067
-12% -$2.72M 0.38% 56
2021
Q1
$22.5M Sell
90,546
-1,279
-1% -$305K 0.46% 48
2020
Q4
$21.1M Buy
91,825
+62
+0.1% +$14.3K 0.44% 50
2020
Q3
$23.3M Sell
91,763
-1,910
-2% -$473K 0.55% 38
2020
Q2
$22.1M Buy
93,673
+558
+0.6% +$127K 0.55% 38
2020
Q1
$18.9M Buy
93,115
+3,349
+4% +$732K 0.55% 42
2019
Q4
$21.6M Sell
89,766
-870
-1% -$192K 0.5% 48
2019
Q3
$17.5M Buy
90,636
+3,383
+4% +$649K 0.44% 52
2019
Q2
$16.1M Sell
87,253
-2,958
-3% -$530K 0.42% 54
2019
Q1
$17.1M Sell
90,211
-282
-0.3% -$53.9K 0.46% 52
2018
Q4
$17.6M Sell
90,493
-195
-0.2% -$38K 0.54% 48
2018
Q3
$18.8M Sell
90,688
-388
-0.4% -$76.5K 0.53% 50
2018
Q2
$16.8M Sell
91,076
-178
-0.2% -$31.5K 0.51% 55
2018
Q1
$15.6M Buy
91,254
+9,425
+12% +$1.73M 0.48% 56
2017
Q4
$14.2M Buy
81,829
+1,980
+2% +$350K 0.42% 66
2017
Q3
$14.9M Sell
79,849
-2,405
-3% -$426K 0.46% 61
2017
Q2
$14.2M Sell
82,254
-6
-0% -$976 0.43% 62
2017
Q1
$13.5M Buy
82,260
+9,261
+13% +$1.54M 0.41% 64
2016
Q4
$10.7M Buy
72,999
+9,074
+14% +$1.37M 0.35% 75
2016
Q3
$10.7M Buy
63,925
+123
+0.2% +$20.8K 0.37% 74
2016
Q2
$9.71M Buy
63,802
+688
+1% +$107K 0.34% 76
2016
Q1
$9.46M Buy
63,114
+5,263
+9% +$782K 0.33% 75
2015
Q4
$9.39M Buy
57,851
+9,073
+19% +$1.43M 0.4% 67
2015
Q3
$6.75M Buy
48,778
+21,559
+79% +$3.4M 0.3% 85
2015
Q2
$4.18M Buy
27,219
+551
+2% +$88.3K 0.17% 116
2015
Q1
$4.26M Sell
26,668
-29
-0.1% -$4.57K 0.18% 116
2014
Q4
$4.25M Sell
26,697
-330
-1% -$51.4K 0.18% 113
2014
Q3
$3.8M Sell
27,027
-878
-3% -$115K 0.17% 113
2014
Q2
$3.3M Sell
27,905
-83
-0.3% -$9.61K 0.14% 127
2014
Q1
$3.45M Sell
27,988
-511
-2% -$62K 0.15% 121
2013
Q4
$3.25M Sell
28,499
-1,651
-5% -$188K 0.14% 122
2013
Q3
$3.37M Sell
30,150
-605
-2% -$65.6K 0.16% 111
2013
Q2
$3.04M Buy
+30,755
New +$3.19M 0.14% 116

Other funds holding AMGN

Fiduciary Trust's AMGN Position: Q1 2026 in Review

Fiduciary Trust reduced its Amgen (AMGN) stake by 0.93% in Q1 2026, selling an estimated $168K and leaving 50,548 shares worth $17.8M. The position accounts for 0.21% of the portfolio, ranked #75.

Fiduciary Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.3M in Q3 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fiduciary Trust held 50,548 shares of Amgen worth $17.8M as of Q1 2026.
  • Fiduciary Trust sold 472 Amgen shares in Q1 2026, an estimated $168K.
  • Amgen made up 0.21% of Fiduciary Trust's portfolio in Q1 2026, its #75 holding.
  • Fiduciary Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's Amgen position peaked at $23.3M in Q3 2020.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.